Valuation: Certara, Inc.

Market Cap 1.04B 907M 838M 774M 1.46B 99.67B 1.48B 10B 3.92B 48.8B 3.9B 3.81B 168B P/E 2026 *
-68.4x
P/E 2027 * -889x
Enterprise Value 1.11B 972M 899M 830M 1.56B 107B 1.59B 10.72B 4.2B 52.32B 4.18B 4.09B 180B EV / Sales 2026 *
2.79x
EV / Sales 2027 * 2.52x
Free-Float
69.31%
Yield 2026 *
-
Yield 2027 * -
1 day-1.77%
1 week-6.97%
Current month+1.83%
1 month+28.27%
3 months+14.60%
6 months-28.43%
Current year-24.29%
1 week 6.45
Extreme 6.45
7.06
1 month 5.24
Extreme 5.24
7.39
Current year 4.45
Extreme 4.45
10.2
1 year 4.45
Extreme 4.45
13.88
3 years 4.45
Extreme 4.45
19.87
5 years 4.45
Extreme 4.45
45.48
10 years 4.45
Extreme 4.45
45.48
Manager TitleAgeSince
Chief Executive Officer 53 01/01/2026
Director of Finance/CFO 53 01/04/2023
President 62 01/08/2023
Director TitleAgeSince
Chairman 72 01/12/2021
Director/Board Member 68 01/01/2013
Director/Board Member 59 01/08/2017
Date Insider Type Main position Quantity % Market Cap.
06-01Fiscal year

Head of Human Resources

16,535 0.0106%
06-01Fiscal year

General Counsel

57,763 0.0371%
05-14Fiscal year

Chairman

64,736 0.0422%
Change 5-day change 1-year change 3-year change Capi.($)
-1.77%-6.97%-40.13%-65.35% 1.04B
-1.55%-1.01%-23.48%+11.50% 2,859B
+2.83%-0.48%-10.35%+715.37% 321B
+1.51%+1.66%+272.06%+920.53% 131B
-0.30%+1.55%+18.68%+56.52% 104B
+4.03%+5.42%+95.05%+149.45% 96.37B
-1.83%-2.46%-22.50%-6.21% 81.55B
-1.24%+4.85%-27.68%+74.86% 66.94B
-2.89%-8.05%-0.60%+58.03% 44.01B
-1.02%-3.95%-51.29%+26.67% 39B
Average +0.49%-1.13%+20.98%+194.14% 374.37B
Weighted average by Cap. +0.65%-0.74%-7.88%+109.78%

Financials

2026 *2027 *
Net sales 399M 348M 322M 298M 561M 38.3B 571M 3.84B 1.51B 18.76B 1.5B 1.46B 64.58B 406M 354M 328M 303M 570M 38.96B 580M 3.91B 1.53B 19.08B 1.52B 1.49B 65.69B
Net income -16.7M -14.59M -13.49M -12.46M -23.47M -1.6B -23.89M -161M -63.11M -785M -62.72M -61.33M -2.7B -2.37M -2.07M -1.92M -1.77M -3.33M -228M -3.39M -22.84M -8.96M -112M -8.91M -8.71M -384M
Net Debt 74.77M 65.34M 60.4M 55.81M 105M 7.18B 107M 720M 283M 3.52B 281M 275M 12.11B -17.2M -15.03M -13.89M -12.84M -24.17M -1.65B -24.61M -166M -65.01M -809M -64.6M -63.17M -2.79B
Logo Certara, Inc.
Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical industry. It accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services, such as regulatory submissions software, natural language processing and Bayesian analytics. It offers both mechanistic and empirical biosimulation solutions, providing clients with a comprehensive offering based on their therapy goals, mechanism of action, and available data sources. Its clients include 2,600 biopharmaceutical companies, academic institutions and biotech companies across 70 countries.
Employees
1,546
Date Price Change Volume
14/07/26 $6.670 -1.77% 2,220,047
13/07/26 $6.790 +0.30% 1,973,526
10/07/26 $6.770 -0.29% 5,392,431
09/07/26 $6.790 +3.82% 2,743,690
08/07/26 $6.540 -8.79% 4,616,205
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
6.670USD
Average target price
7.480USD
Spread / Average Target
+12.14%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CERT Stock